ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

5 Must-Read Analyst Questions From Axon’s Q3 Earnings Call

AXON Cover Image

Axon’s third quarter was marked by robust revenue growth and a negative market reaction, with shares falling significantly after results. Management attributed the top-line momentum to strong demand across software, services, and connected devices, driven by adoption of new AI-powered offerings and deeper customer relationships. CEO Patrick Smith emphasized the rapid uptake of Prepared and Carbyne, highlighting their immediate impact on 911 call center efficiency, while CFO Brittany Bagley pointed to broad-based international and corrections sector wins. However, management acknowledged a notable contraction in operating margin, citing tariffs and increased R&D investment as primary headwinds.

Is now the time to buy AXON? Find out in our full research report (it’s free for active Edge members).

Axon (AXON) Q3 CY2025 Highlights:

  • Revenue: $710.6 million vs analyst estimates of $705.2 million (30.6% year-on-year growth, 0.8% beat)
  • Adjusted EPS: $1.17 vs analyst expectations of $1.54 (24.1% miss)
  • Adjusted EBITDA: $177 million vs analyst estimates of $173 million (24.9% margin, 2.3% beat)
  • Revenue Guidance for Q4 CY2025 is $752.5 million at the midpoint, above analyst estimates of $743 million
  • EBITDA guidance for Q4 CY2025 is $180 million at the midpoint, below analyst estimates of $186.8 million
  • Operating Margin: -0.3%, down from 4.4% in the same quarter last year
  • Annual Recurring Revenue: $1.25 billion vs analyst estimates of $1.22 billion (41.5% year-on-year growth, 2.3% beat)
  • Market Capitalization: $46.14 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Axon’s Q3 Earnings Call

  • George Notter (Wolfe Research) asked about softer bookings and the rationale behind the Prepared and Carbyne acquisitions. CEO Patrick Smith explained the focus on integrating AI into 911 call workflows, stating, “We see Carbyne as the play to go deeper into that voice layer infrastructure.”

  • Jeremy Hamblin (Craig-Hallum) probed the interplay between software/services and connected devices growth. CFO Brittany Bagley responded that software and services will maintain a higher-than-average growth rate, driven by both new customer adoption and feature expansion.

  • Andrew Sherman (TD) sought details on international deals and the trajectory for Body Workforce Mini in retail. COO Joshua Isner highlighted pent-up demand in enterprise, noting, “Enterprise might be the biggest part of our business.”

  • James Fish (Piper Sandler) questioned competitive dynamics in body cameras and the strategic intent behind Carbyne. Isner stressed Axon’s focus on customer needs and ongoing innovation as differentiators in a competitive landscape.

  • Ioannis Samoilis (Baird) inquired about drone and DFR (Drone as First Responder) progress. Smith emphasized growing customer awareness of drone-based threats and described Dedrone as well positioned for longer-term demand across federal and international markets.

Catalysts in Upcoming Quarters

In coming quarters, the StockStory team will be monitoring (1) the pace of customer adoption and integration of Prepared and Carbyne within the Axon ecosystem, (2) the impact of tariffs and ongoing product mix shifts on gross and EBITDA margins, and (3) the expansion of enterprise and international bookings, especially around new body camera and drone solutions. Execution on R&D investments and the scaling of AI-powered offerings will also be key determinants of future performance.

Axon currently trades at $585.99, down from $709.34 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).

The Best Stocks for High-Quality Investors

Fresh US-China trade tensions just tanked stocks—but strong bank earnings are fueling a sharp rebound. Don’t miss the bounce.

Don’t let fear keep you from great opportunities and take a look at Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.14
+0.00 (0.00%)
AAPL  266.25
+0.00 (0.00%)
AMD  206.02
+0.00 (0.00%)
BAC  51.00
+0.00 (0.00%)
GOOG  289.98
+0.00 (0.00%)
META  589.15
+0.00 (0.00%)
MSFT  478.43
+0.00 (0.00%)
NVDA  180.64
+0.00 (0.00%)
ORCL  210.69
+0.00 (0.00%)
TSLA  395.23
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.